Caris Life Sciences vs Leman Biotech
Caris Life Sciences vs Leman Biotech, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Leman Biotech on 48/100.
Where each one leads
Caris Life Sciences
- our overall score: 59/100 against 48/100
- agent readiness: 47/100 against 20/100
- funding raised: $700M against $22.7M
Leman Biotech
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | Leman Biotech |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, HealthTech, Drug Discovery, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2008 | 2021 |
| Headquarters | Irving, United States | Shenzhen, China |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Caris Life Sciences | Leman Biotech |
|---|---|---|
| Employees | 1,659 | Not published |
| Total funding | $700M | $22.7M |
| Latest round | Series D | Series A |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | Leman Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 48/100 |
| Traction | 60/100 | 37/100 |
| Team | Not published | 60/100 |
| Search visibility | 22/100 | 18/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (20/100) |
| Domain ratingLink authority, 0-100 | 62/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | Leman Biotech |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Analytics | Google Tag Manager | Not detected |
Caris Life Sciences vs Leman Biotech: common questions
Which is better, Caris Life Sciences or Leman Biotech?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and Leman Biotech compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 48/100), agent readiness (47/100 against 20/100), funding raised ($700M against $22.7M).
Read the full Caris Life Sciences review and pricing or the Leman Biotech review and pricing. You can also browse other Caris Life Sciences alternatives we track.